MX9705719A - Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratioridea. - Google Patents

Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratioridea.

Info

Publication number
MX9705719A
MX9705719A MX9705719A MX9705719A MX9705719A MX 9705719 A MX9705719 A MX 9705719A MX 9705719 A MX9705719 A MX 9705719A MX 9705719 A MX9705719 A MX 9705719A MX 9705719 A MX9705719 A MX 9705719A
Authority
MX
Mexico
Prior art keywords
parathyroid hormone
analogs
synthesis
related peptide
hormone related
Prior art date
Application number
MX9705719A
Other languages
English (en)
Inventor
Humberto Bartolome Arzeno
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9705719A publication Critical patent/MX9705719A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona un proceso de condensacion de fragmentos para la síntesis de análogos de la hormona paratiroidea (PTH) y el péptido relacionado con la hormona paratiroidea (PTHrP), en el que los residuos aminoácidos (22-31) forman una hélice alfa anfipática sintética.
MX9705719A 1996-07-30 1997-07-29 Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratioridea. MX9705719A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2332296P 1996-07-30 1996-07-30

Publications (1)

Publication Number Publication Date
MX9705719A true MX9705719A (es) 1998-02-28

Family

ID=21814418

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9705719A MX9705719A (es) 1996-07-30 1997-07-29 Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratioridea.

Country Status (30)

Country Link
US (1) US6849710B1 (es)
EP (1) EP0822200B1 (es)
JP (1) JP4229992B2 (es)
KR (1) KR100518982B1 (es)
CN (1) CN1293096C (es)
AR (2) AR008094A1 (es)
AT (1) ATE277080T1 (es)
AU (1) AU731160B2 (es)
BR (1) BR9704138A (es)
CA (1) CA2206008C (es)
CO (1) CO4650046A1 (es)
CZ (1) CZ239697A3 (es)
DE (1) DE69730787T2 (es)
DK (1) DK0822200T3 (es)
ES (1) ES2227639T3 (es)
HR (1) HRP970416A2 (es)
HU (1) HUP9701277A3 (es)
IL (1) IL121391A0 (es)
MA (1) MA24353A1 (es)
MX (1) MX9705719A (es)
NO (1) NO973482L (es)
NZ (1) NZ328411A (es)
PE (1) PE91998A1 (es)
PL (1) PL321391A1 (es)
SG (1) SG67408A1 (es)
TR (1) TR199700714A2 (es)
TW (1) TW505654B (es)
UY (1) UY24651A1 (es)
YU (1) YU32197A (es)
ZA (1) ZA976555B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7015195B2 (en) * 2002-01-10 2006-03-21 Osteotrophin, Llc Treatment of bone disorders with skeletal anabolic drugs
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
CA2628945A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
DK1979370T3 (da) * 2006-01-17 2010-06-28 Organon Nv Selektiv enzymatisk hydrolyse af C-terminale tert-butyl-ester peptider
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
DK2957278T3 (en) 2006-10-03 2017-07-31 Radius Health Inc STABLE COMPOSITION COMPREHENSIVE PTHRP AND APPLICATIONS THEREOF
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
US10087221B2 (en) 2013-03-21 2018-10-02 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
CN104530198B (zh) * 2014-12-09 2017-09-15 兰州大学 一种片段缩合制备醋酸去氨加压素的方法
RU2737496C2 (ru) 2015-04-29 2020-12-01 Радиус Фармасьютикалз, Инк. Способы лечения рака
FI3565542T3 (fi) 2017-01-05 2024-06-24 Radius Pharmaceuticals Inc Rad1901-2hcl:n polymorfisia muotoja
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
EP3765488A1 (en) * 2018-03-12 2021-01-20 Fresenius Kabi iPSUM S.r.l. Process for the manufacture of pthrp analogue
US11643385B2 (en) 2018-07-04 2023-05-09 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCl
CN111057139B (zh) * 2018-10-17 2023-12-22 南京华威医药科技集团有限公司 一种制备特立帕肽的新工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
JPH05509098A (ja) * 1990-07-13 1993-12-16 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア ３，６または９位において変性されている副甲状腺ホルモン類似体
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN

Also Published As

Publication number Publication date
NZ328411A (en) 1998-12-23
KR100518982B1 (ko) 2006-05-29
AR008094A1 (es) 1999-12-09
HU9701277D0 (en) 1997-09-29
KR980009282A (ko) 1998-04-30
AU3236297A (en) 1998-02-05
DK0822200T3 (da) 2005-01-31
CA2206008C (en) 2008-09-23
PE91998A1 (es) 1998-12-31
IL121391A0 (en) 1998-01-04
JPH1077295A (ja) 1998-03-24
JP4229992B2 (ja) 2009-02-25
AR016981A2 (es) 2001-08-01
SG67408A1 (en) 1999-09-21
HUP9701277A2 (hu) 1998-11-30
DE69730787T2 (de) 2005-10-13
HRP970416A2 (en) 1998-08-31
CZ239697A3 (cs) 1998-04-15
TR199700714A2 (xx) 1998-02-21
CN1293096C (zh) 2007-01-03
EP0822200B1 (en) 2004-09-22
ATE277080T1 (de) 2004-10-15
CO4650046A1 (es) 1998-09-03
CN1174845A (zh) 1998-03-04
EP0822200A1 (en) 1998-02-04
UY24651A1 (es) 2000-12-29
MA24353A1 (fr) 1998-07-01
ES2227639T3 (es) 2005-04-01
US6849710B1 (en) 2005-02-01
HUP9701277A3 (en) 2001-02-28
PL321391A1 (en) 1998-02-02
CA2206008A1 (en) 1998-01-30
NO973482L (no) 1998-02-02
DE69730787D1 (de) 2004-10-28
YU32197A (sh) 1999-07-28
AU731160B2 (en) 2001-03-22
NO973482D0 (no) 1997-07-29
TW505654B (en) 2002-10-11
ZA976555B (en) 1998-01-30
BR9704138A (pt) 1998-12-29

Similar Documents

Publication Publication Date Title
MX9705719A (es) Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratioridea.
HK1026215A1 (en) Analogs of parathyroid hormone
AP9901686A0 (en) Peptide parathyroid hormone analogs.
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
EP1405861A3 (en) Analogs of parathyroid hormone
GR3035227T3 (en) Neuroactive peptides
ZA987661B (en) Protein composition and process for isolating a protein composition from a muscle source
EP1094073A3 (en) Analogs of PTH and PTHRP, their synthesis and use for the treatment of osteoporosis
AU3819497A (en) Novel parathyroid hormone-related peptide analogs
TR199701546T1 (xx) Kortikosteroid kaynakl� osteofeni'nin tedavisi i�in metod.
EP0180920A3 (en) Process for cleaving the methionyl link of peptides and proteins
IL79881A0 (en) Method and means for sorting and identifying biological information
MY116969A (en) Coproduction of 6-aminocapronitrile and hexamethylenediamine
GR3023063T3 (en) SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN
ZA903109B (en) Autoantibodies which enhance the rate of a chemical reaction
GB9816514D0 (en) Novel method
EP0110294A3 (en) Agent for the treatment of osteoporose
SG64917A1 (en) Method of peptide synthesis and new synthesis intermediates
MY120723A (en) Method for separating 6- aminocapronitrile from mixtures containing 6- aminocapronitrile and an imine
PL335459A1 (en) Aminopeptidaze obtained from bacillus licheniformis and process for obtaining proteins of natural type
ECSP972207A (es) Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratiroidea (caso ran 4105/190)
ZA979405B (en) Process for isolating a protein composition from a muscle source and protein composition.
MX9707904A (es) Analogos del factor de liberacion de la hormona del crecimiento.
IT1282380B1 (it) Peptide utile come ligando

Legal Events

Date Code Title Description
FG Grant or registration